TY - JOUR
T1 - Ovarian steroids stimulate adenosine triphosphate-sensitive potassium (KATP) channel subunit gene expression and confer responsiveness of the gonadotropin-releasing hormone pulse generator to KATP channel modulation
AU - Huang, Wenyu
AU - Acosta-Martínez, Maricedes
AU - Levine, Jon E.
PY - 2008/5
Y1 - 2008/5
N2 - The ATP-sensitive potassium (KATP) channels couple intracellular metabolism to membrane potential. They are composed of Kir6.x and sulfonylurea receptor (SUR) subunits and are expressed in hypothalamic neurons that project to GnRH neurons. However, their roles in regulating GnRH secretion have not been determined. The present study first tested whether KATP channels regulate pulsatile GnRH secretion, as indirectly reflected by pulsatile LH secretion. Ovariectomized rats received sc capsules containing oil, 17β-estradiol (E2), progesterone (P), or E2+P at 24 h before blood sampling. Infusion of the KATP channel blocker tolbutamide into the third ventricle resulted in increased LH pulse frequency in animals treated with E2+P but was without effect in all other groups. Coinfusion of tulbutamide and the KATP channel opener diazoxide blocked this effect, whereas diazoxide alone suppressed LH. Effects of steroids on Kir6.2 and SUR1 mRNA expression were then evaluated. After 24hr treatment, E2+P produced a modest but significant increase in Kir6.2 expression in the preoptic area (POA), which was reversed by P receptor antagonism with RU486. Neither SUR1 in the POA nor both subunits in the mediobasal hypothalamus were altered by any steroid treatment. After 8 d treatment, Kir6.2 mRNA levels were again enhanced by E2+P but to a greater extent in the POA. Our findings demonstrate that 1) blockade of preoptic/hypothalamic KATP channels produces an acceleration of the GnRH pulse generator in a steroid-dependent manner and 2) E2+P stimulate Kir6.2 gene expression in the POA. These observations are consistent with the hypothesis that the negative feedback actions of ovarian steroids on the GnRH pulse generator are mediated, in part, by their ability to up-regulate KATP channel subunit expression in the POA.
AB - The ATP-sensitive potassium (KATP) channels couple intracellular metabolism to membrane potential. They are composed of Kir6.x and sulfonylurea receptor (SUR) subunits and are expressed in hypothalamic neurons that project to GnRH neurons. However, their roles in regulating GnRH secretion have not been determined. The present study first tested whether KATP channels regulate pulsatile GnRH secretion, as indirectly reflected by pulsatile LH secretion. Ovariectomized rats received sc capsules containing oil, 17β-estradiol (E2), progesterone (P), or E2+P at 24 h before blood sampling. Infusion of the KATP channel blocker tolbutamide into the third ventricle resulted in increased LH pulse frequency in animals treated with E2+P but was without effect in all other groups. Coinfusion of tulbutamide and the KATP channel opener diazoxide blocked this effect, whereas diazoxide alone suppressed LH. Effects of steroids on Kir6.2 and SUR1 mRNA expression were then evaluated. After 24hr treatment, E2+P produced a modest but significant increase in Kir6.2 expression in the preoptic area (POA), which was reversed by P receptor antagonism with RU486. Neither SUR1 in the POA nor both subunits in the mediobasal hypothalamus were altered by any steroid treatment. After 8 d treatment, Kir6.2 mRNA levels were again enhanced by E2+P but to a greater extent in the POA. Our findings demonstrate that 1) blockade of preoptic/hypothalamic KATP channels produces an acceleration of the GnRH pulse generator in a steroid-dependent manner and 2) E2+P stimulate Kir6.2 gene expression in the POA. These observations are consistent with the hypothesis that the negative feedback actions of ovarian steroids on the GnRH pulse generator are mediated, in part, by their ability to up-regulate KATP channel subunit expression in the POA.
UR - http://www.scopus.com/inward/record.url?scp=42449160215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42449160215&partnerID=8YFLogxK
U2 - 10.1210/en.2007-0830
DO - 10.1210/en.2007-0830
M3 - Article
C2 - 18258681
AN - SCOPUS:42449160215
SN - 0013-7227
VL - 149
SP - 2423
EP - 2432
JO - Endocrinology
JF - Endocrinology
IS - 5
ER -